康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00867 康哲药业

已收盘 07-02 16:08:21

11.250

+0.970

+9.44%

最高11.350	最低10.430	成交量1,181万
今开10.660	昨收10.280	日振幅8.95%
总市值273.71亿	流通市值273.71亿	总股本24.33亿
成交额1.32亿	换手率0.49%	流通股本24.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"康哲药业","latestPrice":11.25,"timestamp":1782979701002,"preClose":10.28,"halted":0,"volume":11810247,"delay":0,"changeRate":0.09435797665369657,"floatShares":2433000000,"shares":2433000000,"eps":0.6154,"marketStatus":"已收盘","change":0.97,"latestTime":"07-02 16:08:21","open":10.66,"high":11.35,"low":10.43,"amount":132030141,"amplitude":0.089494,"askPrice":11.25,"askSize":1000,"bidPrice":11.22,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.684786,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":5,"adr":0,"listingDate":1285603200000,"exchange":"SEHK","adjPreClose":10.28,"dividendRate":0.029878,"openAndCloseTimeList":[[1782955800000,1782964800000],[1782968400000,1782979200000]],"volumeRatio":1.301707,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867","defaultTab":"news","newsList":[{"id":"2647376479","title":"康哲药业(00867)：李贤良获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2647376479","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647376479?lang=zh_cn&edition=full","pubTime":"2026-06-29 19:33","pubTimestamp":1782732818,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)发布公告，李贤良先生获委任为独立非执行董事，自2026年6月29日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BVYPNP33.GBP","SG9999004220.SGD","SG9999015945.SGD","IE00BGHQDM52.EUR","BK1593","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD","IE00BVYPNQ40.USD","BK1191","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163936934","title":"康哲药业回购50万股股份，总额约505.89万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163936934","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163936934?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:16","pubTimestamp":1782299769,"startTime":"0","endTime":"0","summary":"康哲药业（00867）于2026年6月24日发布公告，披露公司当日于香港联交所场内回购普通股50万股，占该次股份购回前已发行股本（不包括库藏股）约0.0205%。回购价格区间介乎每股9.94港元至10.22港元，涉资约505.89万港元。\n本次回购完成后，截至2026年6月24日，公司已发行股份总数为24.33131512亿股，库藏股数量为639.7万股。公司股东于2026年4月23日通过购回股份授权，可回购股份总数为2.43952851亿股，至今已购回639.7万股。公司确认，股份回购已获董事会正式授权，遵守香港联交所相关上市规则及其他法律法规。\n本公告由公司秘书吴三燕签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业回购50万股股份，总额约505.89万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645359897","title":"康哲药业(00867.HK)6月24日耗资505.885万港元回购50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645359897","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645359897?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:12","pubTimestamp":1782299572,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BMCWC346.EUR","BK1191","SG9999015952.SGD","LU2488822045.USD","SG9999015945.SGD","SG9999015986.USD","IE00BVYPNP33.GBP","SG9999004220.SGD","BK1593","00867","SG9999015978.USD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","IE00BVYPNQ40.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029055","title":"康哲药业斯乐韦米单抗注射液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029055","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645029055?lang=zh_cn&edition=full","pubTime":"2026-06-22 18:59","pubTimestamp":1782125975,"startTime":"0","endTime":"0","summary":"6月22日，康哲药业发布公告称，公司1类治疗用生物制品斯乐韦米单抗（GR1801）注射液（商品名：金速希?）上市许可申请已获得中国国家药品监督管理局（NMPA）批准，于今日获得药品注册证书。产品用于成人狂犬病病毒暴露者的被动免疫。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606223778186470.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606223778186470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999015952.SGD","LU2488822045.USD","SG9999015986.USD","IE00BVYPNP33.GBP","00867","SG9999015945.SGD","IE00BYV24P56.USD","BK1191","SG9999015978.USD","IPOS","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","BK1593","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115053052","title":"康哲药业6月17日回购40万股，耗资约411.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115053052","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115053052?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:11","pubTimestamp":1781698309,"startTime":"0","endTime":"0","summary":"康哲药业6月17日公告显示，公司于当日在香港联交所回购普通股40万股，约占当日公司已发行股本0.0164%。本次回购价格介乎每股10.20港元至10.32港元，合计支付约411.12万港元。上述股份回购后，公司发行在外的普通股由24.34亿股减少至24.3363亿股，而库藏股数量由549.7万股增至589.7万股。公司总发行股本保持在24.39528512亿股不变。据公告，回购授权于2026年4月23日通过，公司可根据该授权回购最多2.43952851亿股股份。公司表示，上述交易符合既定的回购授权安排和相关规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业6月17日回购40万股，耗资约411.12万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745441","title":"康哲药业(00867)6月17日斥资411.12万港元回购40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745441","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644745441?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:09","pubTimestamp":1781698195,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)发布公告，于2026年6月17日，该公司斥资411.12万港元回购40万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","SG9999015945.SGD","IE00BMCWC346.EUR","00867","BK1191","SG9999015986.USD","SG9999015978.USD","LU2488822045.USD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","IE00BYV24P56.USD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179672205","title":"康哲药业：6月9日回购40.00万股股份，总额约411.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179672205","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179672205?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:26","pubTimestamp":1781000788,"startTime":"0","endTime":"0","summary":"6月9日，康哲药业发布公告显示，公司于香港联合交易所回购40.00万股普通股股份，约占本次回购前公司已发行股本的0.0164%。本次回购价格区间为每股10.23港元至10.35港元，合计支出约411.28万港元。回购完成后，公司已发行股本变更为2,434,031,512股，库存股份增至5,497,000股，总股本维持2,439,528,512股。公司进一步确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由公司秘书吴三燕签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康哲药业：6月9日回购40.00万股股份，总额约411.28万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169289651","title":"康哲药业：6月8日回购101.00万股，耗资约1,043.81万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169289651","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169289651?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:36","pubTimestamp":1780914990,"startTime":"0","endTime":"0","summary":"2026年6月8日，康哲药业公告称，于香港联交所场内回购普通股101.00万股，占该公司当日回购前已发行股本约0.0415%。每股回购价介乎每股港币10.18元至10.45元之间，本次回购总金额约为1,043.81万港元。回购完成后，公司于2026年6月8日的已发行股本由2,435,441,512股减少至2,434,431,512股，同时公司库存股数量由4,087,000股增至5,097,000股。购回授权已于2026年4月23日获得通过，授权购回股份总数为243,952,851股。公司确认，本次回购已遵守香港联合交易所《上市规则》及相关法例的规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业：6月8日回购101.00万股，耗资约1,043.81万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485123","title":"康哲药业(00867)6月8日耗资约1043.81万港元回购101万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641485123?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:32","pubTimestamp":1780914751,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)公布，2026年6月8日耗资约1043.81万港元回购101万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BVYPNQ40.USD","SG9999015986.USD","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","SG9999015952.SGD","IE00BMCWC346.EUR","BK1191","SG9999004220.SGD","LU2488822045.USD","IE00BYV24P56.USD","SG9999015945.SGD","SG9999015978.USD","BK1593","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179599633","title":"康哲药业回购101万股股份，涉资约1,065.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179599633","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179599633?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:21","pubTimestamp":1780568470,"startTime":"0","endTime":"0","summary":"6月4日，康哲药业公告披露，于2026年6月4日在香港联交所场内回购1,010,000股普通股，占该日现有已发行股本约0.0415%。本次回购价格区间介乎每股港币10.45元至10.63元，合计耗资约港币10,651,460元。此外，公司2026年4月23日通过回购授权，可回购股份总数为243,952,851股。公司确认已遵守香港联交所证券上市规则及相关法律法规的规定。公告由公司秘书吴三燕签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业回购101万股股份，涉资约1,065.15万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149743040","title":"康哲药业回购90万股股份，耗资约968.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149743040","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149743040?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:46","pubTimestamp":1780483584,"startTime":"0","endTime":"0","summary":"康哲药业控股有限公司于2026年6月3日发布翌日披露报表，宣布于同日于香港联交所场内回购90万股普通股。根据公告，本次回购占公司现有已发行股本约0.0369%。回购价格介乎每股10.62港元至11.00港元不等，总耗资约9,685,480港元。本次交易后，公司已发行股本由2,437,351,512股降至2,436,451,512股，库藏股数量增至3,077,000股。公司称，此次回购依据2026年4月23日股东大会通过的购回授权进行，该授权允许回购股份总数为243,952,851股，截至目前已累计回购股份3,077,000股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业回购90万股股份，耗资约968.55万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640890529","title":"康哲药业(00867)6月3日斥资968.55万港元回购90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640890529","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640890529?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:44","pubTimestamp":1780483479,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)发布公告，于2026年6月3日，该公司斥资968.55万港元回购90万股股份，每股回购价10.62-11港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BMCWC346.EUR","SG9999015978.USD","IE00BVYPNQ40.USD","SG9999015952.SGD","BK1593","BK1191","IE00BGHQDM52.EUR","IE00BYV24P56.USD","IE00BVYPNP33.GBP","SG9999015986.USD","00867","SG9999015945.SGD","LU2488822045.USD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640597503","title":"医美概念承压 巨子生物(02367)领跌4.08% 机构指敷料药店渠道红利消退、行业进入存量竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2640597503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640597503?lang=zh_cn&edition=full","pubTime":"2026-06-03 13:39","pubTimestamp":1780465177,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医美概念普跌，截至发稿，巨子生物(02367)跌4.08%，医思健康(02138)跌3.66%，复星医药(02196)跌3.16%，康哲药业(00867)跌2.53%，四环医药(00460)跌2.08%，三生制药(01530)跌2.07%。消息面上，华龙证券新近研究指，当前医美行业政策端医保支付监管收紧，医美敷料药店渠道红利消退，行业合规化监管持续深化；医美行业进入存量竞争，循证诊疗、合规经营、精细化运营成为机构发展核心方向。产业端AI智能设备、数字化服务加速在美业线下场景渗透，数智化转型成为行业新趋势，区域美业展会加速全产业链资源整合与模式创新。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982967","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1215","BK1191","BK1600","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","SG9999015945.SGD","BK1511","LU2488822045.USD","00867","02196","SG9999015986.USD","BK1161","IE00BVYPNQ40.USD","BK1207","IE00BMCWC346.EUR","SG9999004311.SGD","00460","SG9999004220.SGD","IE00BYV24P56.USD","BK1515","02367","BK1593","BK1583","SG9999015978.USD","02138","SG9999015952.SGD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130506093","title":"康哲药业6月2日回购65万股，耗资约720.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130506093","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130506093?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:51","pubTimestamp":1780397510,"startTime":"0","endTime":"0","summary":"康哲药业控股有限公司于2026年6月2日回购65万股普通股，约占回购前公司已发行股份总数的0.0267%。此次回购价格介于每股11.00港元至11.16港元，总耗资约720.55万港元。回购的股份将继续作为库藏股持有。公司于2026年4月23日通过了股份购回授权，授权购回上限为2.43952851亿股，至今已于联交所及其他证券交易所合计回购217.7万股，占授权通过当日已发行股份总数的约0.0892%。公司确认，此次回购行为已遵守香港联合交易所有限公司证券上市规则等相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业6月2日回购65万股，耗资约720.55万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640956344","title":"康哲药业(00867)6月1日斥资557.99万港元回购50.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640956344","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640956344?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:16","pubTimestamp":1780312577,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)发布公告，于2026年6月1日斥资557.99万港元回购50.7万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1593","SG9999015986.USD","IE00BVYPNP33.GBP","00867","SG9999004220.SGD","SG9999015978.USD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","SG9999015945.SGD","IE00BVYPNQ40.USD","IE00BMCWC346.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119021673","title":"康哲药业回购507,000股股份，总额约557.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119021673","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119021673?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:16","pubTimestamp":1780312562,"startTime":"0","endTime":"0","summary":"2026年6月1日，康哲药业发布公告称，已于香港联交所场内回购507,000股普通股，占公司现有已发行股份约0.0208%，每股购回价格介乎港元10.75至11.18港元，合计支付约557.99万港元。回购完成后，公司已发行股份由2,438,508,512股减少至2,438,001,512股，库存股增加至1,527,000股，总股份数维持2,439,528,512股不变。公告显示，上述回购根据公司于2026年4月23日通过的购回授权进行，该授权可购回股份总数为243,952,851股。公司确认已遵守香港联交所证券上市规则及相关法律法规。本次公告由公司秘书吴三燕签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业回购507,000股股份，总额约557.99万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144040424","title":"康哲药业5月股份变动月报表：回购1,020,000股列作库存股","url":"https://stock-news.laohu8.com/highlight/detail?id=1144040424","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144040424?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:33","pubTimestamp":1780306388,"startTime":"0","endTime":"0","summary":"康哲药业于2026年6月1日披露了截至2026年5月31日的股份变动月报表。公司本月法定股本维持20,000,000,000股普通股不变，每股面值USD 0.005，总额USD 100,000,000。上月底公司已发行普通股为2,439,528,512股，本月底已发行普通股减至2,438,508,512股，另有1,020,000股被列作库存股，总股本保 持2,439,528,512股。报告显示，5月29日公司按每股HKD10.59的价格回购1,020,000股普通股，相关交易已于4月23日股东大会上获批。此外，本月无新增发行、无股权激励计划变动及可换股票据等事项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178034298","title":"康哲药业回购102万股股份，涉资约1080.69万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178034298","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178034298?lang=zh_cn&edition=full","pubTime":"2026-05-29 19:20","pubTimestamp":1780053656,"startTime":"0","endTime":"0","summary":"中国医疗系统控股有限公司于2026年5月29日发布翌日披露报表，宣布于当日完成股份回购。根据公告，康哲药业当日通过香港联交所回购合计1,020,000股普通股，占回购前公司已发行股份总数约0.0418%。本次回购后，公司已发行股份总数仍为2,439,528,512股，其中2,438,508,512股为已发行股份，另有1,020,000股被纳入库藏股。公司表示，本次回购已获得董事会正式授权，并遵守香港联合交易所证券上市规则及其他相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业回购102万股股份，涉资约1080.69万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639695624","title":"康哲药业(00867)5月29日耗资约1080.69万港元回购102万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639695624","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639695624?lang=zh_cn&edition=full","pubTime":"2026-05-29 19:19","pubTimestamp":1780053566,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)公布，2026年5月29日耗资约1080.69万港元回购102万股股份。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447920.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["SG9999015986.USD","SG9999004220.SGD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","IE00BYV24P56.USD","LU2488822045.USD","SG9999015945.SGD","IE00BVYPNQ40.USD","SG9999015978.USD","00867","BK1593","BK1191","SG9999015952.SGD","IE00BVYPNP33.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638568587","title":"康哲药业(00867)：创新药高选择性TYK2抑制剂CMS-D001获得溃疡性结肠炎适应症和克罗恩病适应症药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2638568587","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638568587?lang=zh_cn&edition=full","pubTime":"2026-05-26 06:30","pubTimestamp":1779748246,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，于2026年5月22日，创新药CMS-D001片获得中国国家药品监督管理局签发的药物临床试验批准通知书，于5月25日收到药物临床试验批准通知书。NMPA同意本集团开展临床试验以评价CMS-D001治疗溃疡性结肠炎适应症和克罗恩病适应症的安全性和有效性。目前，CMS-D001健康受试者I期研究已完成，银屑病和特应性皮炎的Ⅱ期临床试验正在开展中，首例受试者已入组。CMS-D001未来还拟开发用于治疗系统性红斑狼疮等自身免疫病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BYV24P56.USD","LU0661504455.SGD","LU0553294199.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015978.USD","IE00BVYPNP33.GBP","LU0949170772.SGD","IE00BGHQDM52.EUR","LU1003077747.HKD","SG9999015986.USD","LU1894683348.USD","BK1161","CMS","LU1894683264.USD","BK1191","LU2637428348.USD","BK4585","159992","LU0738911758.USD","BK4588","SG9999015952.SGD","BK1593","IE00BMCWC346.EUR","LU2500361329.USD","BK1574","LU0545039389.USD","SG9999004220.SGD","BK4208","06978","LU2346227817.USD","00867","IE00BVYPNQ40.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":-0.0284},{"period":"3month","weight":-0.248},{"period":"6month","weight":-0.1937},{"period":"1year","weight":-0.1217},{"period":"ytd","weight":-0.1937}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0914},{"period":"3month","weight":-0.0954},{"period":"6month","weight":-0.1073},{"period":"1year","weight":-0.0495},{"period":"ytd","weight":-0.1073}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康哲药业控股有限公司是一家主要从事药品生产、营销、推广及销售业务的投资控股公司。该公司的产品包括波依定、优思弗、施图伦滴眼液、喜辽妥、艾蓓尔产品系列及Vmonalisa莫娜丽莎等。其主要在售产品覆盖心脑血管、消化、眼科、皮肤科及医美领域。该公司主要在中国国内和海外市场销售其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.010995},{"month":2,"riseRate":0.6,"avgChangeRate":0.034643},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.007421},{"month":4,"riseRate":0.5,"avgChangeRate":0.025609},{"month":5,"riseRate":0.4375,"avgChangeRate":-0.000081},{"month":6,"riseRate":0.625,"avgChangeRate":0.003785},{"month":7,"riseRate":0.533333,"avgChangeRate":-0.008681},{"month":8,"riseRate":0.4,"avgChangeRate":0.021864},{"month":9,"riseRate":0.466667,"avgChangeRate":0.005632},{"month":10,"riseRate":0.5,"avgChangeRate":0.008421},{"month":11,"riseRate":0.5625,"avgChangeRate":0.05425},{"month":12,"riseRate":0.5625,"avgChangeRate":0.034371}],"exchange":"SEHK","name":"康哲药业","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康哲药业,00867,康哲药业股票,康哲药业股票老虎,康哲药业股票老虎国际,康哲药业行情,康哲药业股票行情,康哲药业股价,康哲药业股市,康哲药业股票价格,康哲药业股票交易,康哲药业股票购买,康哲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}